Adar1 Capital Management, LLC Gossamer Bio, Inc. Transaction History
Adar1 Capital Management, LLC
- $615 Billion
- Q3 2024
A detailed history of Adar1 Capital Management, LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 416,958 shares of GOSS stock, worth $358,583. This represents 0.07% of its overall portfolio holdings.
Number of Shares
416,958
Previous 532,628
21.72%
Holding current value
$358,583
Previous $480 Million
14.29%
% of portfolio
0.07%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding GOSS
# of Institutions
108Shares Held
167MCall Options Held
430KPut Options Held
519K-
Nea Management Company, LLC Timonium, MD18.1MShares$15.6 Million1.37% of portfolio
-
Siren, L.L.C. New York, NY13.3MShares$11.4 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$10.1 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$7.9 Million2.2% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$6.93 Million4.79% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $80.8M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...